| Latest Bsd Medical News Headlines |
| Date | Time | Source | |
| 08/07/2007 | 8:05AM | PRNUS | BSD Medical's Cancer Treatment Systems Get a Proposed 86% Reimbursement Boost
SALT LAKE CITY, Aug. 7 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today reported that the Centers for Medicare and Medicaid Services (CMS) has proposed an approximate 86% increase in the reimbursement rate for all of the CMS codes applicable to the use of BSD cancer treatment systems for hospital outpatient... More...>> |
| 07/20/2007 | 2:12PM | PRNUS | BSD Medical Comments on Recent Decline in Stock Valuation
SALT LAKE CITY, July 20 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today commented on the decline in its stock valuation over recent passed sessions. The company affirms that there is no negative news in its possession pending release and that the company's efforts in concluding its milestones continue... More...>> |
| 07/13/2007 | 8:05AM | PRNUS | 'Hyperthermia: a Potent Enhancer of Radiotherapy' According to August Issue of Clinical Oncology
SALT LAKE CITY, July 13 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today announced that the current issue of Clinical Oncology contains a report entitled "Hyperthermia: a Potent Enhancer to Radiotherapy." The report covers the history of the use of heat (hyperthermia) in treating cancer, from a record on... More...>> |
| 07/10/2007 | 1:17PM | PRNUS | Littleton Radiation Oncology One of Several New Cancer Treatment Centers Now Offering BSD Medical's Hyperthermia Therapy
SALT LAKE CITY, July 10 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today announced that Littleton Radiation Oncology has joined BSD Medical's growing group of U.S. customers, with their acquisition and installation of a BSD-500 Hyperthermia System in their Littleton, Colorado facility. Littleton is a suburb... More...>> |
| 07/09/2007 | 2:36PM | PRNUS | BSD Medical's Patient Website Now Averaging Over 4,000 Hits Per Day
SALT LAKE CITY, July 9 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today reported that the response to the company's patient website has been steadily growing, and through the month of June, the website (http://www.treatwithheat.com/) averaged 4,090 hits per day. BSD's patient website was developed to provide... More...>> |
| 06/22/2007 | 8:05AM | PRNUS | Twelve-Year Survival Data Shows Durability of Hyperthermia Therapy's Enhancement of Radiation in Treating Cancer
SALT LAKE CITY, June 22 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) announced today that a report delivered at the European Society for Hyperthermic Oncology (ESHO) conference recently held in Prague revealed the 12-year follow-up survival data for advanced cervical cancer patients treated with radiation... More...>> |
| 06/11/2007 | 8:05AM | PRNUS | BSD-2000 Cancer Treatment System Acquired in Taiyuan City, China
SALT LAKE CITY, June 11 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today announced that another BSD-2000 cancer treatment system has been purchased and installed in China, at the Shanzi Coal Center Hospital located in Taiyuan City, Shanxi Province. This 800-bed hospital, which treats over 100,000 people... More...>> |
| 06/05/2007 | 2:01PM | PRNUS | Major Study of BSD Medical's Cancer Therapy in Combination With Chemotherapy Highlighted in ASCO News and in Summary Session
SALT LAKE CITY, June 5 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) reported today that the follow-up reviews of the presentation of results from a 340 patient randomized Phase III clinical trial testing the benefit of adding hyperthermia therapy to chemotherapy were both positive and enthusiastic at the American... More...>> |
| 06/04/2007 | 1:36PM | PRNUS | Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival Compared to Chemotherapy Alone for Sarcoma Cancer Patients
SALT LAKE CITY, June 4 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) announced today that the results of a 340 patient randomized Phase III clinical trial testing the benefit of adding hyperthermia therapy to chemotherapy were presented at the annual American Society of Clinical Oncology (ASCO) conference underway... More...>> |
| 06/04/2007 | 10:24AM | PRNUS | Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival Compared to Chemotherapy Alone for Sarcoma Cancer Patients
SALT LAKE CITY, June 4 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) announced today that the results of a 340 patient randomized Phase III clinical trial testing the benefit of adding hyperthermia therapy to chemotherapy were presented at the annual American Society of Clinical Oncology (ASCO) conference underway... More...>> |
| 05/18/2007 | 11:00AM | PRNUS | BSD Medical's Hyperthermia Therapy Now Offered at Cancer Treatment Centers of America
SALT LAKE CITY, May 18 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today announced that Cancer Treatment Centers of America in Philadelphia joined BSD's family of customers with the acquisition and installation of a BSD 500 Hyperthermia System to increase their ability to treat advanced and recurrent cancer... More...>> |
| 05/03/2007 | 8:05AM | PRNUS | BSD Medical Emphasizes Treatment for Head and Neck Cancer at American Brachytherapy Society Annual Conference
SALT LAKE CITY, May 3 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today announced that it has concluded an exhibition at the American Brachytherapy Society (ABS) annual conference held in Chicago, Illinois. The ABS Annual conference provides a forum for reporting developments in brachytherapy. Brachytherapy... More...>> |
| 05/02/2007 | 8:05AM | PRNUS | BSD Medical Corp. Names Dennis Gauger Chief Financial Officer
SALT LAKE CITY, May 2 /PRNewswire-FirstCall/ -- BSD Medical Corporation (AMEX:BSM) today announced the appointment of Dennis P. Gauger as Chief Financial Officer of the Company. Mr. Gauger will serve under contract to the Company, and will assume the role of Principal Accounting Officer with responsibility for certifying... More...>> |
| 05/01/2007 | 8:05AM | PRNUS | European Summit Precedes Announcement of Results of a Major Cancer Study and Further Research for Three Other Cancer Sites
SALT LAKE CITY, May 1 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today announced that a summit meeting called at Atzelberg Castle near Erlangen, Germany involving leading European medical and radiation oncologists has concluded. The purpose of the meeting was to review the results and strategies for major... More...>> |
| 05/01/2007 | 8:05AM | PRNUS | Results of 340 Patient Phase III Study Using BSD Medical's Cancer Therapy Systems to Be Announced at ASCO Annual Meeting
SALT LAKE CITY, May 1 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today announced that the results of a Phase III multi-center, randomized international clinical study involving 340 high-risk soft tissue sarcoma patients will be presented at the American Society of Clinical Oncology (ASCO) 2007 Annual Meeting... More...>> |
| 04/25/2007 | 1:39PM | PRNUS | European Summit Meeting Called in Advance of Clinical Study Announcements
SALT LAKE CITY, April 25 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) stated today that a summit meeting has been called April 26-27 at Atzelberg Castle near Erlangen, Germany involving leading European medical and radiation oncologists focused on the advances in the research of hyperthermia therapy for treating... More...>> |
| 04/20/2007 | 8:05AM | PRNUS | BSD Medical Exhibits the BSD-2000 at Asia's Largest Medical Device Exposition
SALT LAKE CITY, April 20 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today announced that the company and its distributor for China, Dalian Orientech, have concluded an exhibition of the BSD-2000 hyperthermia system at the Chinese International Medical Equipment Fair, Asia's largest medical device exposition... More...>> |
| 04/11/2007 | 8:05AM | PRNUS | FDA Requires No Further Response on Warning Letter
SALT LAKE CITY, April 11 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today stated that the Food and Drug Administration (FDA) has informed the company by letter that BSD's written response to the FDA warning letter (previously announced) is adequate. "Implementations of the corrective actions you have developed... More...>> |
| 04/09/2007 | 8:05AM | PRNUS | BSD Medical to Unveil the New MicroThermX(TM) 100 Thermal Ablation System to Europe at German Radiology Congress
SALT LAKE CITY, April 9 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today announced that the company has arranged to unveil its new MicroThermX 100 thermal ablation system May 16-19 at the 88th Annual German Radiology Congress in Berlin. This annual congress of the German Radiology Society is projected to... More...>> |
| 03/29/2007 | 10:00AM | PRNUS | BSD Medical's Sales and Technical Leaders to Participate in 'Fire and Ice' Symposium in Advance of Introducing the MicroThermX 1
SALT LAKE CITY, March 29 /PRNewswire-FirstCall/ -- BSD Medical Corp. (AMEX:BSM) today announced that, in preparation for its FDA submission and anticipated subsequent market introduction of the MicroThermX 100 system, its sales force and a number of other key management members will participate in the Fire and Ice Symposium... More...>> |